Cargando…

A simplified purification protocol for recombinant adeno-associated virus vectors

We describe a new rapid, low cost, and scalable method for purification of various recombinant adeno-associated viruses (rAAVs) from the lysates of producer cells of either mammalian or insect origin. The method takes advantage of two general biochemical properties of all characterized AAV serotypes...

Descripción completa

Detalles Bibliográficos
Autores principales: Potter, Mark, Lins, Bridget, Mietzsch, Mario, Heilbronn, Regine, Van Vliet, Kim, Chipman, Paul, Agbandje-McKenna, Mavis, Cleaver, Brian D, Clément, Nathalie, Byrne, Barry J, Zolotukhin, Sergei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420252/
https://www.ncbi.nlm.nih.gov/pubmed/26015974
http://dx.doi.org/10.1038/mtm.2014.34
_version_ 1782369682425118720
author Potter, Mark
Lins, Bridget
Mietzsch, Mario
Heilbronn, Regine
Van Vliet, Kim
Chipman, Paul
Agbandje-McKenna, Mavis
Cleaver, Brian D
Clément, Nathalie
Byrne, Barry J
Zolotukhin, Sergei
author_facet Potter, Mark
Lins, Bridget
Mietzsch, Mario
Heilbronn, Regine
Van Vliet, Kim
Chipman, Paul
Agbandje-McKenna, Mavis
Cleaver, Brian D
Clément, Nathalie
Byrne, Barry J
Zolotukhin, Sergei
author_sort Potter, Mark
collection PubMed
description We describe a new rapid, low cost, and scalable method for purification of various recombinant adeno-associated viruses (rAAVs) from the lysates of producer cells of either mammalian or insect origin. The method takes advantage of two general biochemical properties of all characterized AAV serotypes: (i) low isoelectric point of a capsid and (ii) relative biological stability of the viral particle in the acidic environment. A simple and rapid clarification of cell lysate toremove the bulk of proteins and DNA is accomplished by utilizing inexpensive off-the-shelf reagents such as sodium citrate and citric acid. After the low-speed centrifugation step, the supernatant is subjected to cation exchange chromatography via sulfopropyl (SP) column. The eluted virus may then be further concentrated by either centrifugal spin devices or tangential flow filtration yielding material of high titer and Good Manufacturing Practice (GMP) grade biochemical purity. The protocol is validated for rAAV serotypes 2, 8, and 9. The described method makes rAAV vector technology readily available for the low budget research laboratories and could be easily adapted for a large scale GMP production format.
format Online
Article
Text
id pubmed-4420252
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-44202522015-05-26 A simplified purification protocol for recombinant adeno-associated virus vectors Potter, Mark Lins, Bridget Mietzsch, Mario Heilbronn, Regine Van Vliet, Kim Chipman, Paul Agbandje-McKenna, Mavis Cleaver, Brian D Clément, Nathalie Byrne, Barry J Zolotukhin, Sergei Mol Ther Methods Clin Dev Article We describe a new rapid, low cost, and scalable method for purification of various recombinant adeno-associated viruses (rAAVs) from the lysates of producer cells of either mammalian or insect origin. The method takes advantage of two general biochemical properties of all characterized AAV serotypes: (i) low isoelectric point of a capsid and (ii) relative biological stability of the viral particle in the acidic environment. A simple and rapid clarification of cell lysate toremove the bulk of proteins and DNA is accomplished by utilizing inexpensive off-the-shelf reagents such as sodium citrate and citric acid. After the low-speed centrifugation step, the supernatant is subjected to cation exchange chromatography via sulfopropyl (SP) column. The eluted virus may then be further concentrated by either centrifugal spin devices or tangential flow filtration yielding material of high titer and Good Manufacturing Practice (GMP) grade biochemical purity. The protocol is validated for rAAV serotypes 2, 8, and 9. The described method makes rAAV vector technology readily available for the low budget research laboratories and could be easily adapted for a large scale GMP production format. Nature Publishing Group 2014-08-13 /pmc/articles/PMC4420252/ /pubmed/26015974 http://dx.doi.org/10.1038/mtm.2014.34 Text en Copyright © 2014 American Society of Gene & Cell Therapy http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Article
Potter, Mark
Lins, Bridget
Mietzsch, Mario
Heilbronn, Regine
Van Vliet, Kim
Chipman, Paul
Agbandje-McKenna, Mavis
Cleaver, Brian D
Clément, Nathalie
Byrne, Barry J
Zolotukhin, Sergei
A simplified purification protocol for recombinant adeno-associated virus vectors
title A simplified purification protocol for recombinant adeno-associated virus vectors
title_full A simplified purification protocol for recombinant adeno-associated virus vectors
title_fullStr A simplified purification protocol for recombinant adeno-associated virus vectors
title_full_unstemmed A simplified purification protocol for recombinant adeno-associated virus vectors
title_short A simplified purification protocol for recombinant adeno-associated virus vectors
title_sort simplified purification protocol for recombinant adeno-associated virus vectors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420252/
https://www.ncbi.nlm.nih.gov/pubmed/26015974
http://dx.doi.org/10.1038/mtm.2014.34
work_keys_str_mv AT pottermark asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT linsbridget asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT mietzschmario asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT heilbronnregine asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT vanvlietkim asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT chipmanpaul asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT agbandjemckennamavis asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT cleaverbriand asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT clementnathalie asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT byrnebarryj asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT zolotukhinsergei asimplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT pottermark simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT linsbridget simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT mietzschmario simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT heilbronnregine simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT vanvlietkim simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT chipmanpaul simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT agbandjemckennamavis simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT cleaverbriand simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT clementnathalie simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT byrnebarryj simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors
AT zolotukhinsergei simplifiedpurificationprotocolforrecombinantadenoassociatedvirusvectors